Arcadia Biosciences (RKDA) Prices 8.2M Common IPO at $8/Share

Arcadia Biosciences (Nasdaq: RKDA) announced the pricing of its initial public offering of 8,200,000 shares of its common stock at a public offering price of $8.00 per share. The shares are expected to begin trading on The NASDAQ Global Market on May 15, 2015 under the symbol “RKDA.” The offering is expected to close on May 20, 2015, subject to customary closing conditions. In addition, Arcadia Biosciences has granted the underwriters a 30-day option to purchase up to an additional 1,230,000 shares of common stock.

Credit Suisse Securities (USA) LLC and J.P. Morgan Securities LLC are acting as joint lead book-running managers, and Piper Jaffray & Co. is acting as an additional book-running manager, for the offering.

You May Also Be Interested In

• China’s AI leader DeepSeek to file for IPO as soon as this year - report
• Canaan mined 64 BTC in June, holds record 1,915 BTC on balance sheet
• Forge Nano Secures Additional $23 Million in PIPE Financing at $10.00 Per Share, Closes Series D with Samsung Investment Ahead of Public Listing